Medline ® Abstract for Reference 49
of 'Etiology, clinical features, and diagnosis of neonatal hypertension'
49
TI
Dexamethasone associated systemic hypertension in low birth weight babies with chronic lung disease.
AU
Smets K, Vanhaesebrouck P
SO
Eur J Pediatr. 1996;155(7):573.
UNLABELLED:
To assess the role of dexamethasone treatment as a cause of systemic hypertension and associated complications, blood pressure was registered prospectively before, during and after a 4-week dexamethasone course in 22 neonates with chronic lung disease. In all patients systolic blood pressure rose significantly during treatment (median rise 34 mm Hg, range 4-->59 mm Hg), without complications attributable to hypertension. In all but one patient blood pressure returned to pretreatment values within 2 weeks after stopping dexamethasone treatment.
CONCLUSION:
Dexamethasone induced hypertension is transient, even after a 4-week course, and is not associated with hypertensive complications, so treatment is not necessary. When hypertension persists after dexamethasone withdrawal other causes should be considered.
AD
University Children's Hospital, C. Hooft, Neonatal Intensive Care Unit, Ghent, Belgium.
PMID
